« Back
Home /
Alvimopan (dihydrate)

Alvimopan (dihydrate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10 mg
Item no.	HY-76657A-10mg
Targets	Opioid Receptor
CASRN	170098-38-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	460.56314
Clinical_Information	Launched
Manufacturers Research_Area	Neurological Disease; Cancer
Solubility	DMSO : 33.33 mg/mL (ultrasonic)
Manufacturers Target	Opioid Receptor
Isoform	μ Opioid Receptor/MOR
Pathway	GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-76657A-10mg-safety-datasheet.pdf